Alembic Pharmaceuticals receives ANDA approval for Fluoxetine Hydrochloride Tablets

From USFDA

Alembic Pharmaceuticals announced that the Company has received approval from the USFDA for its Abbreviated New Drug Application for Fluoxetine Hydrochloride Tablets, 10 mg and 20 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Prozac Tablets, 10 mg and 20 mg, of Eli Lilly and Company.

Powered by Capital Market - Live News